Literature DB >> 11079727

Human breast cancer cells induced angiogenesis, recruitment, and activation of osteoclasts in osteolytic metastasis.

B Winding1, H Misander, C Sveigaard, B Therkildsen, M Jakobsen, T Overgaard, M J Oursler, N T Foged.   

Abstract

PURPOSE: The purpose of this study was to elucidate the potential of human breast cancer cells (BCC) to induce matrix degradation and neo-vascularization, essential for continued tumor growth, in osteolytic lesions.
METHODS: BCC were inoculated into the left cardiac ventricle of female athymic mice and osteolytic lesions were radiologically visualized within 4 weeks from inoculation.
RESULTS: Histomorphometric analysis of bone sections revealed a significant increase in the number and maturity of osteoclasts (OCl) lining the bone surfaces next to tumor tissue when compared to corresponding bone surfaces in healthy mice. In addition, a large number of newly formed blood vessels could be visualized by immunohistochemistry at the periphery of and within tumor tissue. When bone marrow (BM) cells were cultured in the presence of BCC the OCl formation was increased threefold. These OCl were also found to be more mature and to have greater resorptive activity. Moreover, BCC were found to stimulate proliferation, migration, and differentiation of BM-derived endothelial cells.
CONCLUSIONS: Matrix destruction and neo-vascularization are accomplished by BCC arrested in the BM cavity by increasing recruitment and activity of OCl and by induction of angiogenesis within or in proximity to the tumor tissue.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11079727     DOI: 10.1007/pl00008475

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  7 in total

1.  Transforming growth factor-{beta} coordinately induces suppressor of cytokine signaling 3 and leukemia inhibitory factor to suppress osteoclast apoptosis.

Authors:  Ming Ruan; Larry Pederson; Elizabeth W Bradley; Ana-Maria Bamberger; Merry Jo Oursler
Journal:  Endocrinology       Date:  2010-02-24       Impact factor: 4.736

2.  Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III.

Authors:  Kathrin Niemöller; Christian Jakob; Ulrike Heider; Ivana Zavrski; Jan Eucker; Olaf Kaufmann; Kurt Possinger; Orhan Sezer
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-17       Impact factor: 4.553

3.  Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice.

Authors:  Catalina Suarez-Cuervo; Melinda A Merrell; Latania Watson; Kevin W Harris; Eben L Rosenthal; H Kalervo Väänänen; Katri S Selander
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  Alterations of microvascular density in bone metastases of adenocarcinomas.

Authors:  Tamás Lôrincz; József Tímár; Miklós Szendrôi
Journal:  Pathol Oncol Res       Date:  2004-09-25       Impact factor: 3.201

5.  Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain.

Authors:  Devki Sukhtankar; Alec Okun; Anupama Chandramouli; Mark A Nelson; Todd W Vanderah; Anne E Cress; Frank Porreca; Tamara King
Journal:  Mol Pain       Date:  2011-10-20       Impact factor: 3.395

Review 6.  Osteoclast Fusion: Physiological Regulation of Multinucleation through Heterogeneity-Potential Implications for Drug Sensitivity.

Authors:  Kent Søe
Journal:  Int J Mol Sci       Date:  2020-10-19       Impact factor: 5.923

Review 7.  Osteosarcoma and Metastasis Associated Bone Degradation-A Tale of Osteoclast and Malignant Cell Cooperativity.

Authors:  Kirstine Sandal Nørregaard; Henrik Jessen Jürgensen; Henrik Gårdsvoll; Lars Henning Engelholm; Niels Behrendt; Kent Søe
Journal:  Int J Mol Sci       Date:  2021-06-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.